5 assets in Pancreatic Insulinoma

Therapeutic assets addressing Pancreatic Insulinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Capecitabine Pancreatic Insulinoma	Vanderbilt-Ingram Cancer Center	P2	BB (64)
Edotreotide Pancreatic Insulinoma	British Columbia Cancer Agency	P2	CCC (52)
[68ga]ga-nota-exendin-4 Pancreatic Insulinoma	Peking Union Medical College Hospital	P1	CCC (50)
Exenatide Pancreatic Insulinoma	Peking Union Medical College Hospital	Early P1	CC (43)
FDOPA Pancreatic Insulinoma	Cook Children's Health Care System	P1	CC (43)